Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: A meta-analysis

Chest

Volumn 142, Issue 1, 2012, Pages 63-75

  Diel, Roland ^a   Loddenkemper, Robert ^b   Nienhaus, Albert ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b German Central Committee Against Tuberculosis   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; HIGH RISK POPULATION; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; META ANALYSIS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84863792465     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-3157     Document Type: Article

References (41)

1. World Health Organization. 2011/2012 Tuberculosis Global Facts. Geneva, Switzerland:World Health Organization; 2011.
2. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99(2):131-138.
3. Dye C, Williams BG. Eliminating human tuberculosis in the twenty-first century. J R Soc Interface. 2008;5(23):653-662. (Pubitemid 351589747)
4. Abu-Raddad LJ, Sabatelli L, Achterberg JT, et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A. 2009;106(33):13980-13985.
5. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest. 2010;137(4):952-968.
6. Diel R, Goletti D, Ferrara G, et al. Interferon-γrelease assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37(1):88-99.
7. Sester M, Sotgiu G, Lange C, et al. Interferon-γrelease assays for the diagnosis of active tuberculosis:a systematic review and meta-analysis. Eur Respir J. 2011;37(1):100-111.
8. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):45-55.
9. Moher D, Liberati A, Tetzlaff J, Altman DG;PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
10. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
11. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000;(2):CD001363.
12. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49(RR-6):1-51.
13. Lee SS, Chou KJ, Su IJ, et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection. 2009;37(2):96-102.
14. Kik SV, Franken WP, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J. 2010;35(6):1346-1353.
15. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis -specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 2002;40(2):704-706. (Pubitemid 34130912)
16. Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med. 2008;149(11):777-787.
17. Hill PC, Jackson-Sillah DJ, Fox A, et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE. 2008;3(1):e1379.
18. del Corral H, París SC, Marín ND, et al. IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS ONE. 2009;4(12):e8257.
19. Lienhardt C, Fielding K, Hane AA, et al. Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal [published correction appears in PLoS One. 2010;5(12)]. PLoS ONE. 2010;5(5):e10508.
20. Higuchi K, Harada N, Mori T, Sekiya Y. Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. Respirology. 2007;12(1):88-92. (Pubitemid 44968205)
21. Higuchi K, Kondo S, Wada M, et al. Contact investigation in a primary school using a whole blood interferon-gamma assay. J Infect. 2009;58(5):352-357.
22. Yoshiyama T, Harada N, Higuchi K, Sekiya Y, Uchimura K. Use of the QuantiFERON-TB Gold test for screening tuberculosis contacts and predicting active disease. Int J Tuberc Lung Dis. 2010;14(7):819-827.
23. Silverman MS, Reynolds D, Kavsak PA, Garay J, Daly A, Davis I. Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis. Clin Biochem. 2007;40(12):913-915. (Pubitemid 47077411)
24. Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis. 2009;48(7):954-962.
25. Haldar P, Thuraisingam H, Patel H, Hoskyns W, Woltmann G. QuantiFERON testing in close contacts of smear positive pulmonary TB identifies people at low risk of secondary progression. Thorax. 2010;65(suppl 4):A148.
26. Bradshaw L, Davies E, Devine M, et al. The role of the interferon gamma release assay in assessing recent tuberculosis transmission in a hospital incident. PLoS ONE. 2011;6(6):e20770.
27. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood interferon-γrelease assay for developing active tuberculosis: an update. Am J Respir Crit Care Med. 2011;183(1):88-95.
28. Harstad I, Winje BA, Heldal E, Oftung F, Jacobsen GW. Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers. Int J Tuberc Lung Dis. 2010;14(9):1209-1211.
29. Thomas TA, Mondal D, Noor Z, et al. Malnutrition and helminth infection affect performance of an interferon gammarelease assay. Pediatrics. 2010;126(6):e1522-e1529.
30. Chang B, Park HY, Jeon K, et al. Interferon-γrelease assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Clin Rheumatol. 2011;30(12):1535- 1541.
31. Mahomed H, Hawkridge T, Verver S, et al. The tuberculin skin test versus QuantiFERON TB Gold®in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS ONE. 2011;6(3):e17984.
32. Santin M, Casas S, Saumoy M, et al. Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γrelease assay, and the development of active tuberculosis in HIV-seropositive persons. Diagn Microbiol Infect Dis. 2011;69(1):59-65.
33. Schablon A, Diel R, Diner G, et al. Specificity of a whole blood IGRA in German nursing students. BMC Infect Dis. 2011;11:245.
34. Song S, Jeon D, Kim JW, et al. Performance of confirmatory interferon-gamma release assay in school tuberculosis outbreaks. Chest. 2012;141(4):983-988.
35. Torres Costa J, SáR, Cardoso MJ, et al. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay. Eur Respir J. 2009;34(6):1423-1428.
36. Clark SA, Martin SL, Pozniak A, et al. Tuberculosis antigenspecifi c immune responses can be detected using enzymelinked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol. 2007;150(2):238-244. (Pubitemid 47609557)
37. Jonnalagadda S, Lohman Payne B, Brown E, et al. Latent tuberculosis detection by interferon γrelease assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis. 2010;202(12):1826-1835.
38. Leung CC, Yam WC, Yew WW, et al. T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med. 2010;182(6):834-840.
39. Kim SH, Lee SO, Park JB, et al. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant. 2011;11(9):1927- 1935.
40. Zhang LF, Liu XQ, Zuo LY, Li TS, Deng GH, Wang AX. Longitudinal observation of an interferon gamma-released assay (T-SPOT.TB) for Mycobacterium tuberculosis infection in AIDS patients on highly active antiretroviral therapy. Chin Med J (Engl). 2010;123(9):1117-1121.
41. Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med. 2002;347(23):1860-1866. (Pubitemid 35417778)